Search Results - "Sherrard, L.J."

100 Macrolide resistance is common among members of the CF airway microbiota by Sherrard, L.J, Alawsi, F, McGrath, S, McIlreavey, L, Elborn, J.S, Tunney, M.M

“…Objectives Chronic use of azithromycin has been associated with increased macrolide resistance in recognised CF pathogens. The aims of this study were to…”
Get full text

WS01.6 Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa sub-lineage in cystic fibrosis by Sherrard, L.J, Tai, A, Wee, B.A, Ramsay, K.A, Stockwell, R.E, Kidd, T.J, Whiley, D.M, Beatson, S.A, Bell, S.C

Get full text

100 (More) viable cough aerosols from individuals with cystic fibrosis by Wood, M.E, Johnson, G.R, Stockwell, R.E, Sherrard, L.J, Jabbour, N, Ramsay, K.A, Knibbs, L.D, Kidd, T.J, Wainwright, C.E, Morawska, L, Bell, S.C

Get full text

93 Production of virulence factors by Prevotella isolates belonging to the cystic fibrosis (CF) respiratory microbiota by Sherrard, L.J, Matier, T.B, Nixon, K.A, McGrath, S, McIlreavey, L, Hatch, J, Wolfgang, M.C, Muhlebach, M.S, Gilpin, D.F, Elborn, J.S, Tunney, M.M

“…Objectives The pathogenesis of Prevotella in CF lung infection is not clear. The aim of this study was to determine production of putative virulence factors by…”
Get full text

EPS3.04 Reversal of levofloxacin resistance in cystic fibrosis-associated Pseudomonas aeruginosa through dual inhibition of efflux pumps and DNA topoisomerases by Sloan, C.M., Sherrard, L.J., Einarsson, G.G., Tunney, M.M., Downey, D.G.

Get full text

EPS9.06 Development of levofloxacin resistance in clinical Pseudomonas aeruginosa isolates from people with cystic fibrosis in an in vitro variable exposure model by Sloan, C.M., Sherrard, L.J., Einarsson, G.G., Tunney, M.M., Downey, D.G.

Get full text

ePS3.05 Induced levofloxacin resistance persists in evolved lineages of Pseudomonas aeruginosa isolates from people with cystic fibrosis after exposure to other inhaled antibiotics by Sloan, C.M., Sherrard, L.J., Einarsson, G.G., Tunney, M.M., Downey, D.G.

Get full text

P149 Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis by Sloan, C.M., Sherrard, L.J., Einarsson, G.G., Tunney, M.M., Downey, D.G.

Get full text

P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network by Sloan, C.M., Sherrard, L.J., Einarsson, G.G., Dupont, L.J., van Koningsbruggen-Rietschel, S., Simmonds, N.J., Downey, D.G.

Get full text

P228 In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic fibrosis by Sloan, C.M., Sherrard, L.J., Einarsson, G.G., Hoffman, L.R., Tunney, M.M., Downey, D.G.

Get full text

P150 Antimicrobial prescribing in people with cystic fibrosis: exploring inhaled antibiotic use for Pseudomonas aeruginosa infections across the ECFS-CTN by Sloan, C.M., Sherrard, L.J., Einarsson, G.G., Dupont, L.J., van Koningsbruggen-Rietschel, S., Simmonds, N.J., Downey, D.G.

Get full text

P120 Detection of ceftazidime-avibactam resistance in Pseudomonas aeruginosa isolates by Allen, D., Sherrard, L.J., Einarsson, G.G., Gilpin, D.F., McKenna, J.P., Fairley, D.J., Elborn, J.S., Tunney, M.M.

Get full text

P119 Does pyocyanin production negatively correlate with clinical parameters in people with cystic fibrosis (PWCF) who have infection with Pseudomonas aeruginosa (Pa)? by Allen, D., Sherrard, L.J., Einarsson, G.G., Gilpin, D.F., Elborn, J.S., Bell, S.E.J., Tunney, M.M.

Get full text

P117 Association between Pseudomonas aeruginosa (Pa) strain genotype and viable bacterial community profiles in sputum by Allen, D., Sherrard, L.J., Einarsson, G.G., Gilpin, D.F., McKenna, J.P., Fairley, D.J., Elborn, J.S., Tunney, M.M.

Get full text

P147 Changes in Pseudomonas aeruginosa phenotypes following the development of tobramycin resistance by McCleave, R.P., Li, Z., Einarsson, G.G., Tunney, M.M., Loebinger, M.R., Chalmers, J.D., Elborn, S.J., Haworth, C.S., Sherrard, L.J.

Get full text

P177 Characterisation of pathogens causing lung infection in people with cystic fibrosis by surface-enhanced Raman spectroscopy (SERS) by Allen, D., Kelly, J., Carson, G., Sherrard, L.J., Gilpin, D.F., Elborn, J.S., Bell, S.E.J., Tunney, M.M.

Get full text

P118 Is variation in Pseudomonas aeruginosa Surface-enhanced Raman spectroscopy spectra related to genotype? by Allen, D., Sherrard, L.J., Einarsson, G.G., Gilpin, D.F., Elborn, J.S., McKenna, J.P., Fairley, D.J., Bell, S.E.J., Tunney, M.M.

Get full text

WS02.2 Prevalence of nontuberculous mycobacteria in potable water by Stockwell, R.E., Leong, L.E.X., Wood, M.E., Sherrard, L.J., Carter, R., Tolson, C., Thomson, R.M., Rogers, G., Wainwright, C.E., Bell, S.C.

Get full text

P070 Longitudinal analysis of the lower airway microbiota in cystic fibrosis patients during clinical stability compared to those experiencing episodes of pulmonary exacerbation by Einarsson, G.G., Sherrard, L.J., Johnston, E., O'Neill, K., McIlreavey, L., MCGrath, S.J., Gilpin, D.F., Murray, M., Lavelle, G., MCElvaney, G., Boucher, R., Muhlebach, M., Elborn, J.S., Tunney, M.M.

Get full text

P058 Prevalence of shared Mycobacterium abscessus complex (MABSC) in the Queensland cystic fibrosis population by Stockwell, R.E., Leong, L.E.X., Wheeler, N.E., Bryant, J.M., Wood, M.E., Sherrard, L.J., Thomson, R.M., Rogers, G., Wainwright, C.E., Parkhill, J., Floto, R.A., Bell, S.C.

Get full text